Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Digital health literacy among urban community-dwelling older adults in China: Current status and determinants.

Digital health·2026

Same author

Optimal Reference Panel Design in Ancient DNA Imputation from Coalescent Theory, Simulation, and Real Data Application with an Ancient Reference Panel.

bioRxiv : the preprint server for biology·2026

Same author

A Benchmark of Modern Statistical Phasing Methods.

bioRxiv : the preprint server for biology·2026

Same author

Admixture-informed polygenic risk reporting using the ePRS framework.

Nature communications·2026

Same author

Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome.

Nature genetics·2026

Same author

Relationship between digital health literacy and self-assessment of health among older adults in Xuzhou City: based on the mediating effect of health self-management.

Frontiers in public health·2026

Search research articles

Related Experiment Video

Updated: May 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Progress toward personalized medicine for glaucoma.

Sayoko E Moroi¹, Duna A Raoof, David M Reed

¹Associate Professor, Department of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall Street, Ann Arbor, MI 48105, USA smoroi@umich.edu.

Expert Review of Ophthalmology

|August 6, 2013

Summary

This summary is machine-generated.

Genetic profiling offers hope for personalized glaucoma treatment, moving beyond single-gene to complex multigenic models. Future risk models will integrate gene interactions and environmental factors for better patient outcomes.

Keywords:

aqueous humor dynamics genetics glaucoma intraocular pressure personalized medicine pharmacogenetics pharmacogenomics

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Related Experiment Videos

Last Updated: May 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Area of Science:

Ophthalmology
Genetics
Personalized Medicine

Background:

Glaucoma presents a significant risk of blindness, with family history being a key indicator.
Current treatment approaches often lack personalization, leading to suboptimal outcomes for some patients.
Advances in genomic technologies are enabling a shift towards understanding complex genetic contributions to diseases like glaucoma.

Purpose of the Study:

To explore the potential of genetic profiling in preventing glaucoma-related blindness.
To discuss the integration of genetic markers and behavioral modifications for individualized patient care.
To outline the transition from monogenic to multigenic and environmental models in glaucoma research.

Main Methods:

Reviewing the role of validated disease risk alleles and pharmacogenetic markers.
Investigating the application of genomic technologies for identifying genetic markers.
Analyzing the challenges in developing comprehensive risk prediction models.

Main Results:

Genetic profiling holds promise for tailoring glaucoma treatments to individual patients.
Identification of specific genetic and pharmacogenetic markers is crucial for personalized medicine.
The complexity of glaucoma necessitates considering gene-gene and gene-environment interactions.

Conclusions:

Personalized medicine, driven by genetic insights, is becoming a reality for glaucoma management.
Future glaucoma risk models must incorporate gene-gene interactions, copy-number variations, and environmental factors.
Developing sophisticated risk models is essential to improve treatment efficacy and prevent vision loss.